[HTML][HTML] 嵌合抗原受体NK 细胞治疗肝细胞癌的研究进展

刘思远, 陈琳, 夏安亮, 朱明明, 孙美玲… - 南京医科大学学报(自然 …, 2023 - jnmu.njmu.edu.cn
Harnessing natural killer cells for cancer immunotherapy:dispatching the first responders[J].…
Chimeric antigen receptor(CAR)-NK cell therapy is a new type of tumor immunotherapy, in …

基于NK 细胞的免疫治疗在肝癌中的研究进展.

程世纪, 匡天瑞, 董可帅, 余佳 - Journal of Clinical …, 2023 - search.ebscohost.com
… Research advances in natural killer cell − based immunotherapy in liver cancer … ,and nK
cell r based immunotherapy may succeed in the treatment of liver cancer. This article reviews …

[HTML][HTML] CD39 小分子抑制剂ARL67156 增强NK 细胞对胃癌细胞的杀伤作用

龚英, 何宗忠 - Journal of Southern Medical University, 2023 - ncbi.nlm.nih.gov
… inhibitor of CD39, on cytotoxicity of natural killer (NK) cells against gastric cancer cells. …
ARL67156 treatment without tumor cell stimulation did not induce IFN-γ secretion in NK cells

基于HLA-E 功能特点的肿瘤免疫治疗新策略.

曹朔文, 刘丹, 施明 - Chinese Journal of Cancer Biotherapy, 2022 - search.ebscohost.com
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders[J/OL].
Nat Rev Drug Discov, 2022[2022-03-25]. https:// www.nature.com/articles/s41573-022-…